A crowdfunding campaign is now LIVE on the INVESDOR platform
Together, let’s make Diamidex the future gold standard in industrial microbiological testing !
Our crowdfunding is live! Join our investors today and track the campaign in real time.
June 12 2025 - 6PM CET : Register for our DIAMIDEX live presentation and Q&A session
Keep me posted and get news about the fundraising!
5× Faster Results
With the same accuracy
Recurring Revenue Model
Proprietary consumables generate predictable cash-flow
Global Pull
Already 14 clients generating recurring revenues in 10 countries
Positive impact
Reduced sanitary risk & Destruction of Non-Compliant Products
Proven track record
Already trusted by global leaders in beverage, National and contract laboratories
Pre-Valuation: 12 M€
Amount sought up to 5 M€
Launching our flagship product in 2024 ....
Clients
Trial phases
6 bn€ Adressable Market(+10%/yr)
... with Early Adopters
Testimonials
Being able to enumerate this pathogenic bacterium in only two days is a major step forward in the fight against such microbiological risk.
A method very reliable, suitable and comfortable to use for all, and most important a rapid proven test for the enumeration of Legionella pneumophila.
To be a world-class company, one needs a world-class equipment - and this is where the Diamidex system comes in !